DREAMM9
A Phase 1 Study of Belantamab Mafodotin Plus Standard of Care in Newly Diagnosed Multiple Myeloma
Filters
Save & Share
Clear Filters
Location
Explore options near your patient - or anywhere in the US.
Diagnosis
Treatment History
BCMA Therapy
This stands for B Cell Maturation Antigen (BCMA) and includes treatments such as ide-cel, cilta-cel or belantamab mafodotin.
Near Add Your Location
Sorting 6 by
- Accepting patients
- Show Principal Investigator
- Accepting patients
- Show Principal Investigator
University of Kansas Cancer Center
Kansas City, KS
- Accepting patients
- Show Principal Investigator
- Accepting patients
Victoria Hospital & Children's Hospital
London, ON
- Accepting patients
Ochsner Medical Center
Jefferson, LA
- Not yet accepting
- Show Principal Investigator
1,354 hidden based on your filters. Show All
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.